Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hutchison Medipharma Limited

Clinical trials sponsored by Hutchison Medipharma Limited, explained in plain language.

Hutchison Medipharma Limited HCM NASDAQ

A biopharmaceutical company developing cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 4

New drug combo aims to fight resistant lung cancer

Disease control Ongoing

This phase 3 trial tests whether adding savolitinib to the standard drug osimertinib helps people with a specific type of advanced lung cancer (EGFR-mutant, MET-positive non-small cell lung cancer). About 412 participants will receive either the combination or a placebo plus osim…

Phase: PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC